AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed William Heiden president and CEO...Blueprint Medicines, of Cambridge, Mass., named George Demetri clinical advisor and member of the scientific advisory board...Cynapsus Therapeutics Inc., of Toronto, nominated Perry Molinoff, Thomas Picone and President and CEO Anthony Giovinazzo to its board

Biodel Inc., of Danbury, Conn., added Julia Brown and Davey Scoon to its board...Knopp Biosciences, of Pittsburgh, named Steven Boyd senior director of chemistry and Ian Reynolds senior director of biology...Sernova Corp., of London, Ontario, elected Bruce Weber and James Parsons to its board

XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

China Biologic Products Inc., of Beijing, added Zhijun Tong and Sandy (Han) Zhang to its board...Kolltan Pharmaceuticals Inc., of New Haven Conn., named Gerald McMahon president and CEO...Sorbent Therapeutics, of Sunnyvale, Calif., appointed Howard Dittrich chief medical officer and Randall Woods board chairman

and Santosh Varghese vice president of medical affairs...The company promoted Barbara Troupin to vice president, scientific communication and risk management...named CFO Timothy Morris senior vice president, global corporate development and finance

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Kim Gaumer vice president, regulatory affairs and quality assurance...Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance...Avion Pharmaceuticals LLC, of Atlanta, appointed Michael Sullivan vice president, sales and marketing

Adventrx Pharmaceuticals Inc., of San Diego, formed a regulatory advisory board (RAB) and appointed Cindy Dinella and Bonnie Hepburn to the RAB, with Frank Sasinowski as RAB advisor...InDex Pharmaceuticals AB, of Stockholm, Sweden, appointed Pernilla Sandwall head of clinical operations and Thomas Knittel chief medical officer

Pluristem Therapeutics Inc., of Haifa, Israel, appointed Jeffrey Olin, Manesh Patel, Petra Reinke and J. Andre Schmidt-lucke to its new peripheral artery disease steering committee...PTC Therapeutics Inc., of South Plainfield, N.J., named Claudia Hirawat president and Mark Boulding executive vice president and chief legal officer

3SBio Inc., of Shenyang, China, named Jing Lou board chairman and added Dongmei Su to its board...Anaphore Inc., of La Jolla, Calif., added Peppi Prasit and Raymond Stevens to its board...Silence Therapeutics plc, of London, appointed Detlef Schuppan and Massimo Pinzani to its newly created scientific advisory board

Sirona also appointed Sean Cunliffe chief business officer and board member...Trovagene Inc., of San Diego, named Charlie Rodi vice president and chief technology officer...ValiRx plc, of London, named Hilary Calvert, Richard Harbottle and Jean-Frederic Sauniere to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Rusty" Williams president and CEO and named Brian Atwood chairman

Acella Pharmaceuticals Inc., of Atlanta, appointed Allen Fields vice president and head of R&D...Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Jeff Riley president and CEO, added C. Evan Ballantyne as chief financial officer and named Scott L. Tarriff and Nelson K. Stacks to the board...AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed Rajiv De Silva and Gino Santini to its board

The revisions will reflect technological advancements and marketing developments that have emerged over the past decade...Viewed as a way to take the hard choices of curbing Medicare expenses out of the hands of Congress, the board – made up of presidential appointments confirmed by the Senate – is charged with cutting Medicare costs if its spending exceeds a predetermined target growth rate. (See BioWorld Today, July 14, 2011, and Sept. 20, 2011.) Although President Barack Obama has proposed

It also added John E. Dick and Janet Rossant to its scientific and clinical advisory board...Zealand Pharma A/S, of Copenhagen, Denmark, named Alain Munoz and Christian Grøndahl joint chairs to its new clinical and scientific advisory board

Pharmalink AB, of Stockholm, Sweden, elected Anders Wiklung chairman and added Elisabeth Lindner to the board...Promosome LLC, of New York, added Edward R. Robinson and Loren A. Busby to its board...It also appointed Louis Brenner chief medical officer and elected Kurt Graves chairman

InteRNA Technologies BV, of Utrecht, the Netherlands, appointed Mark Vaeck and Sanne Weijzen to its board chaired by Anker Lundemose...It also named Robert B. Shapiro and Jeffrey B. Kindler to its board

Emerald BioStructures Inc., of Bainbridge Island, Wash., appointed Johan Pontin chairman and CEO...Fate Therapeutics Inc., of San Diego, appointed William H. Rastetter chairman and interim CEO...Forma Therapeutics Inc., of Watertown, Mass., named Jaime Escobedo vice president of biology and Mark J. Tebbe vice president of medicinal and computational chemistry and appointed Dennis France executive director and head of biomolecular screening